Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutasteride for Bladder Wall Hypertrophy in BPH
NCT00827814Phase 4Completed
- Sponsor
- Samsung Medical Center
- Start
- Jun 2006
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dutasteride in benign prostatic hyperplasia (BPH), sponsored by Samsung Medical Center. Primary endpoint: Ultrasound-estimated bladder weight at 6 months. Started Jun 2006; status: completed.
02
Drugs
dutasteride
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00827814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00827814.